August 1, 2007 - Positron Corp. announced that a recent study by The State University of New York at Buffalo reveals that Positron Emission Tomography (PET) scanning when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive and cost effective than SPECT imaging. The research findings, published in the July edition of the Journal of Nuclear Medicine, support PET scanning as the initial diagnostic test for assessing a patient's risk of heart attack, according to lead researcher Michael Merhige, M.D., UB clinical associate professor of nuclear medicine and Director of the Heart Center of Niagara at Niagara Falls Memorial Medical Center. "Because PET scanning is more accurate and provides a clearer picture of the state of the heart than conventional SPECT imaging, we found a decrease in the use of angiograms and bypass surgery by more than 50 percent if used as the first-line test with patients when all too often it is the last test," indicated Dr. Merhige. The study also says that invasive procedures such as coronary arteriography, coronary bypass surgery and stent implantation are over utilized in the U.S., as false readings from SPECT require unnecessary angiograms, for example, that turn out to be normal. PET, however, does not produce as many false positives or false negatives because the images have higher resolution and better contrast, noted Dr. Merhige. For more information: www.positron.com
News | July 31, 2007
PET May Become Initial Diagnostic Test for Heart Attack
News | Neuro Imaging | March 22, 2019
March 22, 2019 — Assessing the patterns of energy use and neuronal activity simultaneously in the human brain improve
Videos | Nuclear Imaging | March 22, 2019
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
News | PET Imaging | March 18, 2019
A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which...
News | Radiopharmaceuticals and Tracers | March 14, 2019
A team of researchers at the University of Washington announced they developed a new automated system for producing...
News | PET-CT | March 06, 2019
Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) system has been...
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...